Both Pfizer and PhRMA funded the Human Rights Campaign's "Healthcare Equality Index," a tool that the far-left organization is using to push gender ideology into medical institutions across the nation.
The HRC's Healthcare Equality Index sways the practices of hospitals and health care facilities by scoring them on whether they are adopting "LGBTQ+ inclusive patient, visitation and employment policies," the The Washington Free Beacon highlighted in a recent report.
The Healthcare Equality Index objectives make it clear that to be scored well, health care institutions must prove they are inclusive of LGBTQ patients, cultivating inclusive workplaces by promoting LGBTQ policies and benefits, and engaging publicly with the LGBTQ community.
The index uses a 100-point scale and awards points for things like displaying LGBT symbols, using patients' preferred pronouns, asking what someone's preferred pronouns are, conducting LGBT training sessions approved by the HRC, and more.
The index also punishes hospitals that allow "Discriminatory treatment that is in conflict with their non-discrimination policy" and requires hospitals to offer the same treatments to treat gender dysphoria as the hospital offers to treat other medical conditions.
The HRC prominently features both Pfizer and PhRMA as funders: "The HEI was funded in part by generous grants from Pfizer Inc. and PhRMA," its website says, referring to the Pharmaceutical Research and Manufacturers of America, a trade group representing companies in the pharmaceutical industry.
Roger Severino, vice president of domestic policy at The Heritage Foundation, told The Daily Signal that Pfizer and PhRMA have turned to an "Ideologically driven interest group to do the dirty work" because federal law prohibits them from "Directly pushing their dangerous drugs on kids with gender confusion."
No comments:
Post a Comment